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Many severe acute respiratory syndrome (SARS)
patients have multiple possible incubation periods due to
multiple contact dates. Multiple contact dates cannot be
used in standard statistical analytic techniques, however. I
present a simple spreadsheet-based method that uses
multiple contact dates to calculate the possible incubation
periods of SARS.
T
he appearance and rapid spread of severe acute respi-
ratory syndrome (SARS), caused by a previously
unknown coronavirus (SARS-CoV) (1–3), has already had
a notable economic and social impact (4,5). SARS has no
definitive cure, although hospitalized patients have been
empirically treated with combinations of antibiotics,
steroids, antiviral drugs (typically ribavirin and
oseltamivir), and mechanical ventilation (6,7). No known
drug can be used prophylactically, nor is does a vaccine
exist. Thus, to stop the spread of the disease, public health
officials have to rely almost completely on placing those
who may have been exposed to SARS-CoV under quaran-
tine and isolating those with suspected, probable, and con-
firmed SARS cases.
To make quarantine and isolation as effective as possi-
ble, knowing the range of the possible incubation period of
SARS is essential. Mathematical modelers also need to
know the characteristics of the incubation period to provide
estimates of possible spread and model the potential impact
of interventions. Many SARS patients often report more
than one possible date of contact with another known SARS
patient (6,7), however, which results in multiple dates of
possible transmission and infection (Table). These multiple
dates prevent early detection of a discrete period of incuba-
tion for each patient, and thus the data from such patients
cannot be used in standard statistical analytic techniques,
such as regression analyses (unless the analyst chooses a
single incubation period from the possible choices) (8).
I present a simple method that allows a simulation of
the frequency distribution, including confidence intervals,
of the possible incubation periods (in days) for SARS. The
method allows use of data from patients with multiple
potential incubation periods. One goal of the method was
to keep it simple by using common computer spreadsheet
software, allowing for easy replication, extension of the
database and results, and rapid dissemination of the
method. The method can also be used to calculate when
infectious persons are most likely to have transmitted
SARS to susceptible persons, even when multiple days of
possible transmission exist.
Methods
I used published data reporting possible incubation
periods for 17 patients (6,7) plus data from two case-
patients in an unpublished database maintained at the
Centers for Disease Control and Prevention (CDC). The
data illustrate a common problem: many patients have
multiple possible incubation periods. I built a simulation
model in a standard computer spreadsheet (Excel 2000,
Microsoft Corp, Redmond, WA) (see online Appendix;
available from: URL: http://www.cdc.gov/ncidod/EID/
vol10no2/03-0426_spreadsht.xls ). I first listed each possi-
ble incubation period for every patient for whom incuba-
tion period data were available (Table). Then, for every
patient, I assigned a random number generator (function
RAND in Excel software) to each possible incubation peri-
od. This method is the equivalent of using a uniform dis-
tribution to select an incubation period from all possible
choices. Using a spreadsheet-based simulation software
package (@Risk, Palisade Corp., Newfield, NY), I pro-
grammed the spreadsheet to run iterations of the model.
During a single iteration, for each patient, the pro-
grammed model selects the incubation period with the
highest random number for that iteration. After a single
iteration, the program calculates the frequency distribution
for the incubation periods. Then, the program assigns
another set of random numbers to each possible incubation
period and selects and calculates the frequency distribu-
tion. After numerous iterations, the program combines all
the frequency distributions from all iterations to provide a
general frequency distribution. From this final frequency
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USAdistribution, descriptive statistics can be obtained, such as
the mean, median, 5th and 95th percentile values. I ran
approximately 10,000 iterations, at which point each addi-
tional iteration caused the mean and the standard distribu-
tion for each possible day of incubation to change by <1%. 
Results
The three largest mean frequencies of incubation peri-
ods among the patients examined were 2, 3, and 6 days
(Figure 1). Incubation periods of 1, 4, 5, and 10 days were
the second highest mean frequencies (Figure 1). However,
the confidence intervals (5th and 95th percentiles) for most
of the potential incubation periods clearly overlapped
(Figure 1). This finding indicates that with the given data
set, an incubation period of 10 days is almost as likely to
occur as an incubation period of 6 days. Using the mean
frequency of each incubation period, I constructed a cumu-
lative frequency graph (Figure 2). The 95th percentile is 12
days, with a median (50th percentile) of approximately 4
days.
Discussion
The incubation period for SARS is likely to be varied,
with the frequency distribution being nonnormal (Figure
1). Thus, using mean incubation periods for activities such
as mathematical modeling will probably result in a misrep-
resentation of SARS transmission. The type of analysis
presented here can help public health officials determine
minimum quarantine periods for persons exposed to
SARS, who are not yet symptomatic. For example, public
health authorities should be aware that in a small percent-
age of case-patients, the incubation period might be >10
days (Figure 2).
Given that data from only 19 patients were available for
this analysis, some caution should be exercised when eval-
uating the results. Adding or subtracting relatively small
numbers of patients can cause estimates such as the 95th
percentile of the cumulative frequency to change. More
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Table. Patients with severe acute respiratory syndrome (SARS) and possible incubation periods 
Possible incubation period of SARS in days  Patient source 
and no.
a  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 
Canada 1    2  3  4  5  6  7  8  9  10  11  12             
Canada 2  1  2  3  4                             
Canada 3  1      4                             
Canada 4  1  2  3  4  5  6  7  8  9  10  11               
Canada 5  1  2  3  4  5  6  7  8  9  10  11  12  13  14         
Canada 7      3              10                 
Canada 8
b      3                               
Canada 10  1  2  3  4  5  6                         
Hong Kong 2    2                                 
Hong Kong 3    2                                 
Hong Kong 4            6                         
Hong Kong 5    2                                 
Hong Kong 6  1  2  3  4  5  6                         
Hong Kong 7          5  6  7  8  9  10  11               
Hong Kong 8          5  6  7  8  9  10  11               
Hong Kong 9  1  2  3  4  5                           
Hong Kong 10    2  3  4  5  6  7                       
USA 1            6              13  14  15  16  17  18 
USA 2              7  8  9  10  11  12             
aPatient source: Canada refers to patients reported in reference 6, Hong Kong to patients reported in reference 7, and USA to patients whose incubation periods were 
extracted from an unpublished database held at CDC. I used the same patient numbers as used in the published reports. 
bPatient 9 from the Canadian database (6) was excluded because the possible incubation period was reported as < 29 days. However, even with n = 20, adding patient 
Canada 9 would mean that possible incubation periods between 19 and 29 days would each have very low frequencies (i.e., <0.01). 
Figure 1. Simulation of frequency distribution of incubation period
of severe acute respiratory syndrome. Data used for this simula-
tion were obtained from Canada (6), Hong Kong (7), and the
United States, for a total sample size of 19. Many of the patients
included in the database had multiple possible incubation periods
(see Table), resulting in the confidence intervals displayed for each
day.data concerning the possible incubation period of SARS
patients are needed. The advantage of the method used
here is that such data need not be specific. The method
readily “accepts” data in which patients have multiple pos-
sible incubation periods. More data will likely reduce the
confidence intervals for the frequencies of each incubation
day (Figure 1), giving a clearer picture of the actual fre-
quency distribution of all incubation periods.
The method can also be readily adapted to examine
other aspects of SARS epidemiology when unambiguous
data are scarce. For example, with the appropriate data,
this method can be used to examine the frequency distribu-
tion of when an infectious person infects other people. (An
Excel workbook [Excel 2000, Microsoft, Corp, Redmond,
WA] containing the model used to calculate the results
shown in Figures 1 and 2, and using the data shown in the
Table, is available on line from: URL: http://www.cdc.gov/
ncidod/EID/vol10no2/03-0426_spreadsht.xls ). Also, dis-
tributions of incubation periods can be used to examine
whether an association exists between incubation period
and likelihood of hospitalization or death.
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Figure 2. Cumulative frequency incubation period of severe acute
respiratory syndrome. Data are the mean frequencies of each indi-
vidual incubation period, as shown in Figure 1. Data used for this
simulation were obtained from Canada (6), Hong Kong (7), and the
United States, for a sample size 19. Many of the patients included
in the database had multiple possible incubation periods (see
Table).